Subjects = 19 or = 75 years of age
Subjects undergoing treatment for type 2 diabetes
Subjects undergoing treatment of statin for hypercholesterolemia
Fasting LDL-C = 250mg/dL at the screening visit
Fasting LDL-C =70mg/dL or = 160mg/dL at the randomization visit
Fasting TG<500mg/dL

NCT03217409_inc_T1
Value
= 19 or = 75 years
NCT03217409_inc_T2
Person
age
NCT03217409_inc_T3
Condition
type 2 diabetes
NCT03217409_inc_T4
Procedure
treatment
NCT03217409_inc_T5
Procedure
treatment
NCT03217409_inc_T6
Condition
hypercholesterolemia
NCT03217409_inc_T7
Drug
statin
NCT03217409_inc_T8
Scope
treatment of statin
NCT03217409_inc_T9
Measurement
Fasting LDL-C
NCT03217409_inc_T10
Measurement
Fasting LDL-C
NCT03217409_inc_T11
Value
= 250mg/dL
NCT03217409_inc_T12
Temporal
at the screening visit
NCT03217409_inc_T13
Value
=70mg/dL
NCT03217409_inc_T14
Value
= 160mg/dL
NCT03217409_inc_T15
Scope
=70mg/dL or = 160mg/d
NCT03217409_inc_T16
Temporal
at the randomization visit
NCT03217409_inc_T17
Measurement
Fasting TG
NCT03217409_inc_T18
Value
<500mg/dL
NCT03217409_inc_T19
Temporal
at the randomization visit